Oncolytic virotherapy against the tumor microenvironment and its potential in pancreatic cancer

被引：6

作者：

Zhang, Yalei ^{[1
,2
]}

Li, Ye ^{[2
]}

Chen, Kun ^{[1
,2
]}

Qian, Ling ^{[1
,2
]}

Wang, Peng ^{[1
,2
]}

机构：

[1] Fudan Univ, Dept Integrat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China

[2] Shanghai Med Coll, Fudan Univ, Dept Oncol, Shanghai, Peoples R China

来源：

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS | 2022年 / 18卷 / 05期

基金：

中国国家自然科学基金;

关键词：

Clinical trial; oncolytic virus; pancreatic cancer; tumor microenvironment; ENDOTHELIAL GROWTH-FACTOR; HSG-BINDING DOMAIN; PHASE-I; THERAPEUTIC AGENT; VIRUS THERAPY; ADENOVIRUS; ANGIOGENESIS; REPLICATION; GEMCITABINE; INJECTION;

D O I：

10.4103/jcrt.jcrt_91_21

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Emerging evidence has revealed the critical role of the tumor microenvironment (TME) in tumor progression, angiogenesis, metastasis, and immunosuppression. Oncolytic viruses (OVs), a versatile therapeutic agent that targets both cancer cells and the TME, have emerged as a promising candidate for antitumor therapy. Strategies of manipulating OVs against the TME include normalization of the tumor vasculature, decomposition of the tumor stroma, and reversion of the immunosuppressive microenvironment. In pancreatic cancer, desmoplastic stroma comprises up to 80% of the tumor mass, accompanied by hypovascularity and profound immunosuppression, conferring a particularly important role to TME-targeted oncolytic virotherapy. Mechanisms and supporting evidence of OVs reversing the tumor-privileged TME and applications of TME-targeted OVs for pancreatic cancer are summarized in this review.

引用

页码：1247 / 1255

页数：9

共 72 条

[51] Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma [J].

Provenzano, Paolo P. ;

Cuevas, Carlos ;

Chang, Amy E. ;

Goel, Vikas K. ;

Von Hoff, Daniel D. ;

Hingorani, Sunil R. .

CANCER CELL, 2012, 21 (03) :418-429

[52] Oncolytic viral therapy for pancreatic cancer [J].

Rahal, Ahmad ;

Musher, Benjamin .

JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (01) :94-103

[53] Tumor microenvironment participates in metastasis of pancreatic cancer [J].

Ren, Bo ;

Cui, Ming ;

Yang, Gang ;

Wang, Huanyu ;

Feng, Mengyu ;

You, Lei ;

Zhao, Yupei .

MOLECULAR CANCER, 2018, 17

[54] Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy [J].

Ribas, Antoni ;

Dummer, Reinhard ;

Puzanov, Igor ;

VanderWalde, Ari ;

Andtbacka, Robert H. I. ;

Michielin, Olivier ;

Olszanski, Anthony J. ;

Malvehy, Josep ;

Cebon, Jonathan ;

Fernandez, Eugenio ;

Kirkwood, John M. ;

Gajewski, Thomas F. ;

Chen, Lisa ;

Gorski, Kevin S. ;

Anderson, Abraham A. ;

Diede, Scott J. ;

Lassman, Michael E. ;

Gansert, Jennifer ;

Hodi, F. Stephen ;

Long, Georgina V. .

CELL, 2017, 170 (06) :1109-1119

[55] Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression [J].

Rodriguez-Garcia, Alba ;

Gimenez-Alejandre, Marta ;

Rojas, Juan J. ;

Moreno, Rafael ;

Bazan-Peregrino, Miriam ;

Cascallo, Manel ;

Alemany, Ramon .

CLINICAL CANCER RESEARCH, 2015, 21 (06) :1406-1418

[56] Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD [J].

Rojas, J. J. ;

Gimenez-Alejandre, M. ;

Gil-Hoyos, R. ;

Cascallo, M. ;

Alemany, R. .

GENE THERAPY, 2012, 19 (04) :453-457

[57] Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region [J].

Saito, Y ;

Sunamura, M ;

Motoi, F ;

Abe, H ;

Egawa, S ;

Duda, DG ;

Hoshida, T ;

Fukuyama, S ;

Hamada, H ;

Matsuno, S .

CANCER GENE THERAPY, 2006, 13 (03) :242-252

[58] 4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer [J].

Sakellariou-Thompson, Donastas ;

Forget, Marie-Andree ;

Creasy, Caitlin ;

Bernard, Vincent ;

Zhao, Li ;

Kim, Young Uk ;

Hurd, Mark W. ;

Uraoka, Naohiro ;

Parra, Edwin Roger ;

Kang, Ya'an ;

Bristow, Christopher A. ;

Rodriguez-Canales, Jaime ;

Fleming, Jason B. ;

Varadhachary, Gauri ;

Javle, Milind ;

Overman, Michael J. ;

Alvarez, Hector A. ;

Heffernan, Timothy P. ;

Zhang, Jianhua ;

Hwu, Patrick ;

Maitra, Anirban ;

Haymaker, Cara ;

Bernatchez, Chantale .

CLINICAL CANCER RESEARCH, 2017, 23 (23) :7263-7275

[59] Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: Virus persists and spreads systemically at late time points [J].

Sauthoff, H ;

Hu, J ;

Maca, C ;

Goldman, M ;

Heitner, S ;

Yee, H ;

Pipiya, T ;

Rom, WN ;

Hay, JG .

HUMAN GENE THERAPY, 2003, 14 (05) :425-433

[60] Immunotherapy for pancreatic cancer: A 2020 update [J].

Schizas, Dimitrios ;

Charalampakis, Nikolaos ;

Kole, Christo ;

Economopoulou, Panagiota ;

Koustas, Evangelos ;

Gkotsis, Efthymios ;

Ziogas, Dimitrios ;

Psyrri, Amanda ;

Karamouzis, Michalis, V .

CANCER TREATMENT REVIEWS, 2020, 86

← 1 2 3 4 5 6 7 8 →